Please login to the form below
Brexit
This page shows the latest Brexit news and features for those working in and with pharma, biotech and healthcare.
Future of MHRA uncertain amid Brexit-fuelled shake up
After Brexit, the EMA moved its headquarters from London to Amsterdam, with the unions saying “fewer staff will therefore be asked to cover more ground with fewer resources, all while operating ... The budget cuts are driven by Brexit, which had seen
Latest news
-
MHRA outlines two-year delivery plan with ‘patient first’ focus
New delivery plan also outlines strategy for UK regulatory body following Brexit.
-
Responsibly growing our talent pool
Despite the devastating effect the pandemic, and perhaps Brexit, are inflicting on the economy as a whole, in healthcare communications there is still a growing need for new talent and a
-
A happier new year?
However, with effective vaccination programmes, perhaps we can dare plan for a much better second half of the year, at least until we start to factor in the impact of Brexit.
-
Chancellor’s ‘coronavirus budget’ also pledges big R&D gains
Away from the coronavirus measures, there was very little mention of Brexit, but plenty to digest for the biopharma industry in a budget that seems to mark a return to the
-
It’s Brexit day – now comes the really hard stuff
Michael Warren, who covers Brexit and trade issues for the BIA, said that there’s been no change to the industry position on the negotiation phase for the trade deal. ... It’s worth noting that despite the disruption caused by the build-up to Brexit,
More from news
Approximately 173 fully matching, plus 79 partially matching documents found.
Latest Intelligence
-
The need for a refreshingly different approach to achieving behaviour change
Today, the cost-of-living crisis – caused by wage and benefit reductions, soaring energy prices, inflation, Brexit, the COVID-19 pandemic and international conflict – is driving considerable risk for population health
-
Unlocking the potential of data sharing
market. How Brexit has affected data sharing in clinical trials. During COVID-19, we saw how important it was for countries to share information quickly, which was bourne out by the
-
Are smart deals a clever solution to UK market access?
It is happening at pace, driven by a unique combination of factors including Brexit, COVID-19 and NHS reforms.
-
Setting up for success in a post-Brexit, post-pandemic Britain
the prospect of Brexit has done little to dampen confidence in this sector. ... Dealing with Brexit. Brexit has, and will continue to have, a significant impact on the pharmaceutical and healthcare sector.
-
A new era for UK-Japanese scientific research relations
This denotes the strategic importance that the UK government gives to the region as it finds its feet in a post-Brexit world. ... This role has increased since Brexit and can be critical in delivering the fastest and most effective trials.
More from intelligence
Approximately 20 fully matching, plus 52 partially matching documents found.
Latest from PMHub
-
The Seven Year Switch
People’s relationships have become strained and defined by their views on Trump, Brexit, vaccines and global warming – with flames being fanned by social media.
-
Is COVID-19 yet another barrier to contraceptive access?
In addition to the existing barriers such as Brexit-related stock uncertainty and an increased demand for the products, the global supply chain for these products was now experiencing the challenges
-
2020 - a year to remember or forget?
But let us not forget the political backdrop with elections, Brexit, a Royal abdication, bushfires, #metoo, Black Lives Matter and a renewed focus on diversity and inclusion, and don’t forget
-
Let's be ambitious for patients and life sciences investment in Global Britain
Yet with the sector seen as crucial to economic regeneration post-Brexit and post-pandemic, the slower use of innovative medicines in the UK is a drag anchor on the ... In post-Brexit ‘Global Britain’, Government wants a rejuvenated MHRA to help the
-
HOW INNOVATION IS RESHAPING THE NORTH EAST LIFE SCIENCES LANDSCAPE
This trend is vitally important at a time when the region is considering its post Brexit economic future. ... In a post Brexit Britain where the UK’s future trading relationship with the EU remains uncertain, adopting more innovative business practices
More from PMHub
Approximately 4 fully matching, plus 15 partially matching documents found.
Subscribe to our email news alerts
- Contagious Conversations: Exploring Infectious Disease in the Digital Age
- Austrian State Secretary to speak at FlyPharma Europe 2023
- Further data for AstraZeneca/Daichii Sankyo’s Enhertu for breast cancer requested by NICE
- Gritstone Bio receives $433m BARDA contract for COVID-19 vaccine candidate
- EDX Medical Group develops multi-disease 'point-of-care' rapid tests for cancer, infections and cardiovascular conditions
- ScreenPoint Medical to showcase AI software at European scientific meeting
No results were found
PMHub
Wisepress
Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...
Latest intelligence
- The importance of accelerating clinical trial diversity
- Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
- Digital Opinion Leaders: The Role of Influencers in Medical Communications
- There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
- Creating Hope Though Action – World Suicide Prevention Day
- At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....
